MAXIPURE
LIVE

Serial Number

79420187

Owner

EVONIK OPERATIONS GMBH

Attorney

Scott D. Woldow

Filing Date

Oct 17, 2024

Add to watchlist:

No watchlists yet
View on USPTO

MAXIPURE Trademark

Serial Number: 79420187

MAXIPURE is a trademark filed by EVONIK OPERATIONS GMBH on October 17, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

EVONIK OPERATIONS GMBH (457 trademarks)

RELLINGHAUSER STRASSE 1-11
ESSEN 45128 , DE

Entity Type: 16

Trademark Details

Filing Date

October 17, 2024

Registration Date

Not Registered

Goods & Services

Chemical additives for use in the manufacture of pharmaceuticals; chemical excipients and chemical intermediates for use in the manufacture of pharmaceutical products; amino acids for industrial purposes; peptides substrates for industrial purposes; proteins for use in industry, proteins for the food industry; proteins for use in pharmaceutical and nutritional product manufacturing; saccharide preparations, used as an ingredient in the manufacture of pharmaceutical and nutritional products, other than for medical use; galactose for industrial pharmaceutical and nutritional purposes; mannose for industrial purposes; antioxidants for use in the manufacture of pharmaceuticals; lipids for use in industry, namely, used in the manufacture of cosmetics, beverages, food products and food supplements; chemical preparations for use in the food industry; chemical preparations for the manufacture of food supplements; chemical excipients and chemical intermediate products for use in the manufacture of foodstuffs, in particular food supplements; chemical additives for use in the manufacture of probiotic products; chemical additives for use in the manufacture of pharmaceuticals, foodstuffs and pharmaceutical products; probiotic bacterial formulations, other than for medical use; bacteria for use in food manufacture; bacterial preparations for the food industry; probiotic bacteria for the food industry; bacterial cultures for addition to food products; probiotic bacterial cultures for the food industry; milk ferments for the food industry; bacteria for use in the manufacture of food supplements, food, nutritional products, pharmaceutical products and cosmetics; bacteriological cultures mediums, other than for medical and veterinary use; bacterial products, other than for medical and veterinary use; bacterial preparations, other than for medical and veterinary use; chemical analysis diagnostic kits comprising specimen receptors and reagents for testing for selected bacteria, other than for medical or veterinary purposes; catalysts, in particular biochemical catalysts; chemical substances for preserving foodstuffs, none of the aforesaid products for use in the manufacture of insecticides, adjuvants, agricultural chemicals, forestry, horticulture, energy and well drilling.

Pharmaceutical and veterinary preparations for the treatment of nutritional conditions, bacteriological conditions, and probiotic conditions; bacterial preparations for medical and veterinary preparations; chemical preparations for medical, pharmaceutical and veterinary purposes, namely, nucleic acid sequences and chemical reagents; veterinary preparations, namely, antioxidants; adjuvants for medical purposes; amino acids for medical and veterinary purposes; amino acid preparations for medical, veterinary and pharmaceutical purposes; synthetic peptides for pharmaceutical purposes for the treatment of nutritional conditions; cellulose esters, fats, and oils for medical and veterinary uses; salts, in particular potassium and sodium salts for medicinal purposes; steroids; biological preparations for the treatment of probiotic conditions for medical and veterinary purposes; ferments for pharmaceutical purposes; yeast for dietary and pharmaceutical purposes; starch for dietary and pharmaceutical purposes; enzymes and enzyme preparations for medical and veterinary purposes; bacterial and bacteriological preparations for medical or veterinary purposes; bacterial poisons; cultures of microorganisms for medical or veterinary use; nutritive substances for microorganisms for medical or veterinary purposes; bouillons for bacteriological cultures for medical purposes or veterinary purposes; biological tissue cultures for medical and veterinary purposes; pharmaceutical preparations and substances for the treatment of damaged skin and tissue, namely, tissue-regenerative preparations; probiotic supplements; probiotic bacterial formulations for veterinary use; probiotic bacterial formulations for medical use; probiotic preparations for dietary purposes; probiotic preparations for medical use to help maintain a natural flora in the digestive system; probiotic preparations for medicinal purposes to maintain a natural flora in the digestive system; dietetic foods and products adapted for medical and veterinary purposes; dietetic foods adapted for medical purposes; albuminous preparations for medical purposes, namely, albumin dietary supplements; candy, medicated; medicinal drinks; dietetic beverages adapted for medical purposes; medical preparations for slimming purposes; food for babies; dietary supplements for human beings; dietary supplements for animals; dietary supplements; dietetic preparations adapted for medical use; capsules sold empty for pharmaceutical purposes; sugar, in particular rock sugar and dextrose for medical purposes; glucose for medical purposes; albuminous foodstuffs for medical purposes, namely, albumin supplements; protein dietary supplements; dietary fiber for treating constipation; mineral dietary supplements; chemical preparations, namely, preparations of trace elements for medical and veterinary use; vitamin preparations.

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 12, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 12, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 12, 2026 TROA
REFUSAL PROCESSED BY IB
Aug 2, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 11, 2025 RFCS
REFUSAL PROCESSED BY MPU
Jul 11, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 15, 2025 RFCR
NON-FINAL ACTION WRITTEN
May 14, 2025 CNRT
ASSIGNED TO EXAMINER
Apr 1, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 31, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 31, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 27, 2025 REPR